Hypercalcemia of malignancy

From IDWiki
Revision as of 01:17, 4 July 2020 by Maintenance script (talk | contribs) (Imported from text file)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Mechanisms

  • PTHrP secretion (humoral hypercalcemia)
    • Squamous cell carcinoma, renal carcinoma, bladder carcinoma, breast carcinoma, ovarian carcinoma, prostate carcinoma, colorectal carcinoma, Non-Hidgkin lymphoma, CML, leukemia, lymphoma
  • Osteolytic metastases
    • Breat carcinoma, multiple myeloma, lymphoma, leukemia
  • 1,25-dihydroxyvitamin D production
    • Lymphoma (most common), ovarian dysgerminoma
  • Ectopic PTH secretion
    • Ovarian carcinoma, lung carcinoma, neuroextodermal, thyroid papillary carcinoma, rhabdomyosarcoma, pancreatic carcinoma

Clinical Presentation

  • Signs and symptoms of hypercalcemia (bones, moans, groans, overtones)
  • Volume depleted
  • Altered mental status
  • Constipation

Management

  • Indications for treatment:
    • Calcium >3.5 is dangerous!
    • Symptoms of hypercalcemia, especially if in the 3 to 3.5 range
  • IV fluids 200 to 300 mL/h initially
  • Salmon calcitonin 4 u/kg
    • Continue every 6 to 12 hours if calcium responds
  • Zoledronic acid 4mg IV over 15 minutes or pamidronate 60 to 90 mg IV over 2 hours